Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cassava Sciences, Inc.

https://www.cassavasciences.com/

Latest From Cassava Sciences, Inc.

Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19

2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.

Commercial Sales & Earnings

Hotter Than Oncology? China Immunology Players Raise $650m

The China bioventure sector is poised to set a record for initial public offerings and fundraising, but one therapeutic area is taking a surprise lead - immunology.

China Financing

Supreme Court To Decide Constitutionality Of Patent Trial and Appeal Board Judges

US high court agrees to hear case that could impact hundreds of patent decisions by PTAB; damage caused by continuing uncertainty ‘cannot be overstated,’ New York IP law association says.

Intellectual Property Legal Issues

Swedish Firms Pledpharma And RTT Merge To Target Orphan Drug Space

Following the failure of PledOx, Pledpharma is joining forces with Rare Thyroid Therapeutics to target orphan treatments, initially focusing on the latter's investigational therapy for MCT8 deficiency.

Rare Diseases M & A
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Pain Therapeutics, Inc.
UsernamePublicRestriction

Register